By L.B. Bohle
To get in touch with L.B. Bohle, simply fill out the form below.
Subscribe to Supplier
L.B. Bohle bringing solid dose manufacturing advances to INTERPHEX 2023 in New York
Ennigerloh, Germany: – World-respected builder of advanced systems for pharma production, L.B. Bohle, will return to the high prestige INTERPHEX pharma expo in New York to show significant advances in solid dose manufacturing.
L.B. Bohle LLC will be exhibiting from Booth 1101 at the Javits Center in New York City with a display that includes two cutting edge machines.
QbCon® 1: Unique truly continuous granulator and dryer
The QbCon® 1 offers an optimal starter system for Continuous Manufacturing (CM), with a truly continuous wet granulator and dryer system for R&D that guarantees an increase in product quality while at the same time increasing flexibility and operator safety. In addition, the use of process analytics reduces resource consumption and shortens development times.
In contrast to competitive systems, QbCon® 1 realizes a permanent, truly continuous process without the formation of sub-batches and blocked filters.
BFC 50 used machine as a special offer
At INTERPHEX, the L.B. Bohle team will present a pre-owned BFC 50 TriPan with short delivery time and reduced price. This 2016 model is in perfect condition and has only run for about 150 hours and is also prepared for High Containment. Full factory warranty is also included.
The BFC 50 TriPan tablet coater is a flexible coating system that can be operated with three pans.
By using different pans, batch sizes between seven and 75 liters can be realized. The Bohle BFC coaters guarantee first-class product processing and excellent economy.
CM technologies and support center
In addition to these two machine highlights, the Bohle team will present the latest information on its evolving technologies for Continuous Manufacturing.
They will also have information about the company’s comprehensive product portfolio for weighing, dry and wet granulation, sieving and milling, tablet coating and product handling using augmented reality technologies and 3D models.
The Bohle team will also promote the work of the state-of-the-art U.S. Service Center at Warminster, PA, where customers can test or optimize all steps in the tablet manufacturing process.
The center provides pharmaceutical, chemical, and nutraceutical professionals with an enhanced environment for testing and technical training, process development and process optimization and hands-on seminars.
It is equipped with a wide range of machines, including Dry granulation BRC, QbCon 1 Twin Screw Granulation & Truly Continuous Drying, BFC 5 and BTC 100 Laboratory and Tablet Coaters, BTS 200 conical sieve, BTM 150 hammer mill, LM 40 and PM 400 Blenders, and Semi-automatic IBC Washer.
About L.B. Bohle
Founded in 1981, L.B. Bohle Maschinen und Verfahren GmbH (L.B. Bohle) has established a worldwide reputation as a producer and supplier of advanced systems for pharmaceutical manufacturing, based on a track record of technological innovation and continuous improvement.
Based at Ennigerloh in Northwest Germany, L.B. Bohle operates worldwide, offering advanced solutions for every aspect of oral solid dose (OSD) and nutraceutical tablet production, including weighing & dosing, grinding & sieving, blending, tablet coating, sorting, handling systems, cleaning and containment, process monitoring and continuous manufacturing.
The company’s guiding vision is one of technological innovation in the production of pharmaceutical solids. This supports a core mission to deliver maximum product efficiency increases for its customers, through continuous development and product innovations that not only increase quality and efficiency, but also strengthen competitive edge and sustainability.
To these ends, L.B. Bohle offers both complete production lines and solutions for individual production steps, focusing on rapid development and production of sophisticated, pragmatic, and customized applications.
The company operates development and manufacturing facilities at its home base at Ennigerloh and at Sassenberg, both in North Rhine-Westphalia. Additionally, it has sales and service subsidiaries in the USA (Warminster, PA) in India (Ahmedabad), in Singapore and in Switzerland (Reiden). It is also represented by more than 40 qualified sales partners worldwide, having become a globally recognized brand.
About INTERPHEX 2023
Over more than 40 years, America’s International Pharmaceutical Expo (INTERPHEX or IPX) has become established as one of the world’s leading single source events for biopharmaceutical and pharmaceutical manufacturing and processing solutions and technologies.
The 43rd INTERPHEX Expo aims to showcase the full range of state-of-the-art solutions needed for cost-effective product development and manufacture, including equipment, accessories and technologies while offering networking and peer-to-peer sharing opportunities, presentations, and interactive demonstrations.
INTERPHEX 2022 is a three-day event opening April 25, once again at the Javits Center in New York City. The event is sponsored by the Parenteral Drug Association (PDA).
IPX is organized by organized by Reed Exhibitions with more information at: http://www.interphex.com